In a major milestone for women’s health company Natural Cycles, the company has announced the closing of a $55 million Series C financing round, bringing its total funding to over $95 million. Founded in 2013 by Dr. Elina Berglund Scherwitzl and Dr. Raoul Scherwitzl, Natural Cycles developed the world’s first birth control app that has been used by over three million users globally. It is the only digital form of birth control cleared by regulators in the US, Europe, Canada, Australia, Singapore, and South Korea.
Lauxera Capital Partners led the funding round with participation from Point72 Private Investments and a revolving debt facility from J.P. Morgan. Lauxera’s founding partner, Samuel Levy, praised Natural Cycles for its unique technology and vision in transforming women’s health. He highlighted the company’s profitable growth and clinical and regulatory business moats. Levy will join Natural Cycles’ Board of Directors as part of the investment.
The funds will be used to accelerate commercial efforts, develop new products, and automate healthcare reimbursement processes. As part of this effort, Natural Cycles recently launched NC° Postpartum within its app to provide support for new mothers recovering from childbirth. This new mode adds to the existing options in the Natural Cycles app – NC° Birth Control, NC° Plan Pregnancy, and NC° Follow Pregnancy.
Dr. Raoul Scherwitzl expressed excitement about the funding and the company’s mission to make hormone-free birth control more accessible to women around the world.”We are thrilled to have secured this additional funding,” he said.”With these resources at our disposal
